Latest Breaking News On - Isa odidi - Page 23 : comparemela.com
Intellipharmaceutics Announces Second Quarter 2021 Results
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Intellipharmaceutics Announces Closing of CAD$3 85 Million Non-Brokered Private Placement
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Closing of CAD$3.85 Million Non-Brokered Private Placement
TORONTO, ON / ACCESSWIRE / April 22, 2021 /
Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ( Intellipharmaceutics or the Company ), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, is pleased to announce the completion of a non-brokered private placement (the Private Placement ) of 9,414,560 common shares of the Company (the Common Shares ) at a price of CAD$0.41 per Common Share for total gross proceeds of CAD$3,859,969.60.
The proceeds of the Private Placement are expected to be used to maintain the Company s existing operations and for general working capital purposes and to fund research and development activities.
Intellipharmaceutics International Inc.: Intellipharmaceutics Announces First Quarter 2021 Results
TORONTO, ON / ACCESSWIRE / April 14, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ( Intellipharmaceutics or the Company ), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today reported the results of operations for the three months ended February 28, 2021. All dollar amounts referenced herein are in United States dollars unless otherwise noted.
On July 2, 2020, the Company had announced that the parties in the cases, numbers 17-cv-392-RGA, 18-cv-404-RGA and 20-cv-515-RGA (the Litigations ) between Purdue Pharma L.P. et al ( Purdue ) and Intellipharmaceutics entered into a stipulated dismissal of the Litigations. The stipulated dismissal, which was subject to approval by the bankruptcy court presiding over Purdue Pharma s pending chapter
Intellipharmaceutics Announces First Quarter 2021 Results
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.